Key Insights
The global H. Pylori Test market is projected for substantial growth, estimated to reach $214.4 million by 2025, with a Compound Annual Growth Rate (CAGR) of 7.4% from 2025 to 2033. This expansion is driven by the rising incidence of H. pylori infections, a primary cause of peptic ulcers, gastritis, and gastric cancer. Increased awareness of H. pylori diagnostics and demand for accurate, rapid testing solutions, including immunoassay and molecular diagnostics, are key growth factors. Point-of-Care (POC) testing is expected to gain traction due to its convenience and speed.
H. Pylori Test Industry Market Size (In Million)
The market's growth will be further supported by favorable reimbursement policies and government initiatives for gastrointestinal health. Leading companies are investing in R&D for more sensitive and specific diagnostic kits, such as non-invasive breath and stool antigen tests. Potential restraints include the cost of advanced diagnostic equipment and alternative treatment options. North America and Europe are expected to lead due to developed healthcare infrastructure, while the Asia Pacific region is anticipated to exhibit the fastest growth, driven by increasing healthcare spending and a large patient population.
H. Pylori Test Industry Company Market Share
Global H. Pylori Test Market Analysis: Dynamics, Outlook, and Key Players (2019-2033)
This comprehensive report provides an in-depth analysis of the global H. Pylori Test market, examining market dynamics, technological progress, competitive landscapes, and future growth. It offers actionable insights and data for industry professionals, researchers, and investors. The study covers the historical period (2019-2024), base year (2025), and forecasts market trends through 2033.
H. Pylori Test Industry Market Dynamics & Structure
The H. Pylori Test Industry is characterized by a moderate to high level of market concentration, with key players investing heavily in research and development to introduce innovative diagnostic solutions. Technological innovation is a primary driver, fueled by the increasing demand for accurate, rapid, and non-invasive H. pylori detection methods. Regulatory frameworks, such as those set by the FDA and EMA, play a crucial role in shaping product approvals and market access, ensuring the safety and efficacy of diagnostic tests. Competitive product substitutes, including invasive endoscopic procedures, are gradually being overshadowed by the superiority of advanced H. pylori testing kits. End-user demographics are diverse, encompassing hospitals, clinics, and diagnostic laboratories, each with unique testing volume and technology preferences. Mergers and acquisitions (M&A) trends are observed as companies seek to expand their product portfolios, geographical reach, and technological capabilities, further consolidating the market.
- Technological Innovation: Driven by the need for point-of-care (POC) solutions and improved assay sensitivity.
- Regulatory Landscape: Strict approval processes influence product launches and market entry strategies.
- Competitive Product Substitutes: Endoscopic biopsies are declining in favor of immunoassay and molecular tests.
- End-User Adoption: Growing preference for non-invasive stool and breath tests among patients and clinicians.
- M&A Activity: Strategic acquisitions by larger players to gain market share and access novel technologies.
H. Pylori Test Industry Growth Trends & Insights
The H. Pylori Test Industry is poised for significant growth, driven by the rising global prevalence of H. pylori infections, a leading cause of peptic ulcers and gastric cancer. The market size evolution is projected to be robust, with increasing adoption rates of advanced diagnostic technologies. Technological disruptions, particularly in the realm of molecular diagnostics and point-of-care (POC) testing, are revolutionizing detection methods, offering greater accuracy and speed. Consumer behavior shifts are also contributing to market expansion, with a growing awareness of H. pylori's health implications and a preference for less invasive diagnostic approaches. The base year of 2025 reflects a strong market foundation, with the forecast period of 2025-2033 anticipating sustained, accelerated growth. The market penetration of rapid diagnostic kits is expected to deepen, supported by favorable reimbursement policies and an increasing focus on early disease detection and management. The CAGR is projected to be in the range of 7-9% during the forecast period, signifying a healthy and expanding market.
- Market Size Evolution: Anticipated to reach over $3,000 million units by 2033, up from an estimated $1,500 million units in 2025.
- Adoption Rates: Increasing uptake of immunoassay and molecular diagnostic tests, replacing traditional methods.
- Technological Disruptions: Proliferation of highly sensitive and specific POC tests and breath tests.
- Consumer Behavior Shifts: Growing demand for non-invasive and convenient diagnostic options.
- Market Penetration: Deeper reach into emerging economies with improving healthcare infrastructure.
Dominant Regions, Countries, or Segments in H. Pylori Test Industry
North America and Europe currently represent the dominant regions in the H. Pylori Test Industry, driven by advanced healthcare infrastructure, high per capita healthcare spending, and a strong emphasis on early disease detection. The United States and Germany, in particular, are key contributors due to their large patient populations and well-established diagnostic laboratory networks. Within the technology segment, Immunoassays currently hold the largest market share due to their cost-effectiveness, ease of use, and widespread availability. However, Molecular diagnostics are experiencing rapid growth, offering superior sensitivity and specificity, and are expected to gain significant traction. The Point of Care (POC) segment is also a major growth driver, enabling faster diagnosis in clinical settings and remote areas. Hospitals and clinics are the primary end-users, owing to their direct patient interaction and the need for immediate diagnostic results. Diagnostic laboratories also represent a substantial segment, processing a high volume of tests. Emerging economies in Asia-Pacific are anticipated to witness the fastest growth, fueled by increasing healthcare expenditure, rising awareness of gastrointestinal diseases, and a growing number of diagnostic laboratories.
- Dominant Regions: North America and Europe lead due to advanced healthcare systems and robust R&D investments.
- Leading Countries: United States, Germany, Japan, and China are key markets for H. Pylori testing.
- Dominant Technology Segment: Immunoassays currently lead in market share, followed by Molecular Diagnostics and Point of Care (POC) tests.
- Primary End-User Segment: Hospitals and clinics, followed by diagnostic laboratories, are the largest consumers of H. Pylori tests.
- Growth Potential: Asia-Pacific and Latin America are projected to exhibit the highest growth rates in the coming years.
H. Pylori Test Industry Product Landscape
The H. Pylori Test Industry product landscape is characterized by continuous innovation aimed at enhancing diagnostic accuracy, reducing turnaround times, and improving patient comfort. Key product categories include urea breath tests, stool antigen tests (immunoassays and immunochromatography), serological antibody tests, and molecular diagnostic tests like PCR. Recent product launches have focused on developing highly sensitive and specific assays with minimal cross-reactivity. For instance, advancements in immunoassay technology have led to stool antigen tests that offer excellent sensitivity and specificity, comparable to invasive methods. Molecular diagnostic tests are emerging as a powerful tool, capable of detecting H. pylori DNA with high precision, and also identifying antibiotic resistance genes. Point-of-care (POC) devices are also gaining prominence, enabling rapid results within minutes at the physician's office or clinic.
Key Drivers, Barriers & Challenges in H. Pylori Test Industry
Key Drivers:
- Rising Prevalence of H. Pylori Infections: The increasing incidence of H. pylori-related gastrointestinal disorders globally is a primary growth catalyst.
- Technological Advancements: Development of more accurate, rapid, and non-invasive diagnostic methods.
- Growing Awareness of H. Pylori Health Risks: Increased patient and healthcare provider understanding of the link between H. pylori and serious conditions like gastric cancer.
- Government Initiatives and Healthcare Policies: Support for early disease detection and screening programs.
- Demand for Point-of-Care (POC) Diagnostics: Preference for decentralized testing solutions offering quick results.
Barriers & Challenges:
- High Cost of Advanced Technologies: Molecular diagnostic tests can be more expensive than traditional immunoassay kits, limiting accessibility in certain regions.
- Regulatory Hurdles: Stringent approval processes for new diagnostic tests can delay market entry.
- Lack of Standardized Testing Protocols: Variations in testing methodologies can lead to discrepancies in results.
- Competition from Invasive Procedures: While declining, endoscopic biopsies still hold a place in diagnosis, especially for complex cases.
- Reimbursement Policies: Inconsistent or inadequate reimbursement for certain H. pylori tests can impact adoption.
Emerging Opportunities in H. Pylori Test Industry
The H. Pylori Test Industry presents several emerging opportunities for growth and innovation. The development of multiplex molecular assays capable of detecting H. pylori and key antibiotic resistance genes simultaneously is a significant area of opportunity, aiding in personalized treatment strategies. Expansion into underserved emerging markets, particularly in Asia-Pacific and Africa, where H. pylori prevalence is high but diagnostic access is limited, offers substantial untapped potential. The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms to enhance data analysis and predictive capabilities for H. pylori-related diseases represents another promising avenue. Furthermore, the development of novel point-of-care testing devices with improved user-friendliness and connectivity for remote patient monitoring is a growing trend.
Growth Accelerators in the H. Pylori Test Industry Industry
The long-term growth of the H. Pylori Test Industry is being accelerated by several key factors. Continuous technological breakthroughs, such as the refinement of CRISPR-based diagnostics and the development of highly sensitive biosensors, promise to further revolutionize H. pylori detection. Strategic partnerships between diagnostic test manufacturers, pharmaceutical companies, and healthcare providers are fostering wider adoption and improved patient care pathways. Market expansion strategies targeting developing economies, coupled with efforts to increase healthcare infrastructure and awareness, will unlock significant growth potential. The increasing focus on precision medicine and companion diagnostics will also drive demand for sophisticated H. pylori testing solutions that can guide targeted therapies and improve treatment outcomes.
Key Players Shaping the H. Pylori Test Industry Market
- Meridian Bioscience
- CTK Biotech Inc
- Diagnostic BioSystems
- Medline Industries LP
- CerTest BIOTEC
- Epitope Diagnostics Inc
- Biohit Oyj
- Bio-Rad Laboratories
- Coris BioConcept SPRL
- Exalenz Bioscience Ltd
- Quest Diagnostics Incorporate
- Thermo Fisher Scientific
- TECHLAB Inc
Notable Milestones in H. Pylori Test Industry Sector
- May 2022: Biomerica, Inc. announced CE Mark for its hp+detect diagnostic test that detects Helicobacter pylori bacteria, paving the way for its marketing and sale in the European Union and other international markets.
- April 2021: Otsuka launched QuickNaviTM-H.pylori, a Helicobacter pylori Quick Detection Kit. This immunochromatography-based kit provides rapid (eight minutes) confirmation of H. pylori antigens in stool samples, primarily for use in medical institutions.
In-Depth H. Pylori Test Industry Market Outlook
The In-Depth H. Pylori Test Industry Market Outlook indicates a highly promising future, driven by an increasing global health imperative to manage and eradicate H. pylori infections. Growth accelerators such as advanced molecular diagnostics, the expansion of point-of-care testing capabilities, and the strategic penetration into emerging markets will collectively propel the industry forward. The rising incidence of H. pylori-related gastrointestinal diseases and cancers continues to fuel the demand for accurate and efficient diagnostic solutions. Innovations in multiplex testing, enabling simultaneous detection of the bacteria and antibiotic resistance markers, will redefine treatment protocols. Strategic collaborations and sustained R&D investments are anticipated to unlock new market segments and solidify the industry's growth trajectory, promising significant opportunities for stakeholders focused on enhancing global gastrointestinal health.
H. Pylori Test Industry Segmentation
-
1. Technology
- 1.1. Immunoassays
- 1.2. Point of Care (POC)
- 1.3. Molecular diagnostics
- 1.4. Others
-
2. End-user
- 2.1. Hospitals and clinics
- 2.2. Diagnostic laboratories
- 2.3. Others
H. Pylori Test Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
H. Pylori Test Industry Regional Market Share
Geographic Coverage of H. Pylori Test Industry
H. Pylori Test Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.4% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Infections Diseases; Increasing Awareness about the Infections Among People
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Norms by Government
- 3.4. Market Trends
- 3.4.1. Immunoassay Segment is Expected to Witness Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 5.1.1. Immunoassays
- 5.1.2. Point of Care (POC)
- 5.1.3. Molecular diagnostics
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by End-user
- 5.2.1. Hospitals and clinics
- 5.2.2. Diagnostic laboratories
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 6. North America H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 6.1.1. Immunoassays
- 6.1.2. Point of Care (POC)
- 6.1.3. Molecular diagnostics
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - by End-user
- 6.2.1. Hospitals and clinics
- 6.2.2. Diagnostic laboratories
- 6.2.3. Others
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 7. Europe H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 7.1.1. Immunoassays
- 7.1.2. Point of Care (POC)
- 7.1.3. Molecular diagnostics
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - by End-user
- 7.2.1. Hospitals and clinics
- 7.2.2. Diagnostic laboratories
- 7.2.3. Others
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 8. Asia Pacific H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 8.1.1. Immunoassays
- 8.1.2. Point of Care (POC)
- 8.1.3. Molecular diagnostics
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - by End-user
- 8.2.1. Hospitals and clinics
- 8.2.2. Diagnostic laboratories
- 8.2.3. Others
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 9. Middle East and Africa H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 9.1.1. Immunoassays
- 9.1.2. Point of Care (POC)
- 9.1.3. Molecular diagnostics
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - by End-user
- 9.2.1. Hospitals and clinics
- 9.2.2. Diagnostic laboratories
- 9.2.3. Others
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 10. South America H. Pylori Test Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 10.1.1. Immunoassays
- 10.1.2. Point of Care (POC)
- 10.1.3. Molecular diagnostics
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - by End-user
- 10.2.1. Hospitals and clinics
- 10.2.2. Diagnostic laboratories
- 10.2.3. Others
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Meridian Bioscience
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 CTK Biotech Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Diagnostic BioSystems
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Medline Industries LP
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 CerTest BIOTEC
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Epitope Diagnostics Inc
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Biohit Oyj
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Bio-Rad Laboratories
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 CorisBioConcept SPRL
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Exalenz Bioscience Ltd
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Quest Diagnostics Incorporate
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Thermo Fisher Scientific
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 TECHLAB Inc
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.1 Meridian Bioscience
List of Figures
- Figure 1: Global H. Pylori Test Industry Revenue Breakdown (million, %) by Region 2025 & 2033
- Figure 2: Global H. Pylori Test Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America H. Pylori Test Industry Revenue (million), by Technology 2025 & 2033
- Figure 4: North America H. Pylori Test Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 5: North America H. Pylori Test Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 6: North America H. Pylori Test Industry Volume Share (%), by Technology 2025 & 2033
- Figure 7: North America H. Pylori Test Industry Revenue (million), by End-user 2025 & 2033
- Figure 8: North America H. Pylori Test Industry Volume (K Unit), by End-user 2025 & 2033
- Figure 9: North America H. Pylori Test Industry Revenue Share (%), by End-user 2025 & 2033
- Figure 10: North America H. Pylori Test Industry Volume Share (%), by End-user 2025 & 2033
- Figure 11: North America H. Pylori Test Industry Revenue (million), by Country 2025 & 2033
- Figure 12: North America H. Pylori Test Industry Volume (K Unit), by Country 2025 & 2033
- Figure 13: North America H. Pylori Test Industry Revenue Share (%), by Country 2025 & 2033
- Figure 14: North America H. Pylori Test Industry Volume Share (%), by Country 2025 & 2033
- Figure 15: Europe H. Pylori Test Industry Revenue (million), by Technology 2025 & 2033
- Figure 16: Europe H. Pylori Test Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 17: Europe H. Pylori Test Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 18: Europe H. Pylori Test Industry Volume Share (%), by Technology 2025 & 2033
- Figure 19: Europe H. Pylori Test Industry Revenue (million), by End-user 2025 & 2033
- Figure 20: Europe H. Pylori Test Industry Volume (K Unit), by End-user 2025 & 2033
- Figure 21: Europe H. Pylori Test Industry Revenue Share (%), by End-user 2025 & 2033
- Figure 22: Europe H. Pylori Test Industry Volume Share (%), by End-user 2025 & 2033
- Figure 23: Europe H. Pylori Test Industry Revenue (million), by Country 2025 & 2033
- Figure 24: Europe H. Pylori Test Industry Volume (K Unit), by Country 2025 & 2033
- Figure 25: Europe H. Pylori Test Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: Europe H. Pylori Test Industry Volume Share (%), by Country 2025 & 2033
- Figure 27: Asia Pacific H. Pylori Test Industry Revenue (million), by Technology 2025 & 2033
- Figure 28: Asia Pacific H. Pylori Test Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 29: Asia Pacific H. Pylori Test Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 30: Asia Pacific H. Pylori Test Industry Volume Share (%), by Technology 2025 & 2033
- Figure 31: Asia Pacific H. Pylori Test Industry Revenue (million), by End-user 2025 & 2033
- Figure 32: Asia Pacific H. Pylori Test Industry Volume (K Unit), by End-user 2025 & 2033
- Figure 33: Asia Pacific H. Pylori Test Industry Revenue Share (%), by End-user 2025 & 2033
- Figure 34: Asia Pacific H. Pylori Test Industry Volume Share (%), by End-user 2025 & 2033
- Figure 35: Asia Pacific H. Pylori Test Industry Revenue (million), by Country 2025 & 2033
- Figure 36: Asia Pacific H. Pylori Test Industry Volume (K Unit), by Country 2025 & 2033
- Figure 37: Asia Pacific H. Pylori Test Industry Revenue Share (%), by Country 2025 & 2033
- Figure 38: Asia Pacific H. Pylori Test Industry Volume Share (%), by Country 2025 & 2033
- Figure 39: Middle East and Africa H. Pylori Test Industry Revenue (million), by Technology 2025 & 2033
- Figure 40: Middle East and Africa H. Pylori Test Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 41: Middle East and Africa H. Pylori Test Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 42: Middle East and Africa H. Pylori Test Industry Volume Share (%), by Technology 2025 & 2033
- Figure 43: Middle East and Africa H. Pylori Test Industry Revenue (million), by End-user 2025 & 2033
- Figure 44: Middle East and Africa H. Pylori Test Industry Volume (K Unit), by End-user 2025 & 2033
- Figure 45: Middle East and Africa H. Pylori Test Industry Revenue Share (%), by End-user 2025 & 2033
- Figure 46: Middle East and Africa H. Pylori Test Industry Volume Share (%), by End-user 2025 & 2033
- Figure 47: Middle East and Africa H. Pylori Test Industry Revenue (million), by Country 2025 & 2033
- Figure 48: Middle East and Africa H. Pylori Test Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Middle East and Africa H. Pylori Test Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Middle East and Africa H. Pylori Test Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: South America H. Pylori Test Industry Revenue (million), by Technology 2025 & 2033
- Figure 52: South America H. Pylori Test Industry Volume (K Unit), by Technology 2025 & 2033
- Figure 53: South America H. Pylori Test Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 54: South America H. Pylori Test Industry Volume Share (%), by Technology 2025 & 2033
- Figure 55: South America H. Pylori Test Industry Revenue (million), by End-user 2025 & 2033
- Figure 56: South America H. Pylori Test Industry Volume (K Unit), by End-user 2025 & 2033
- Figure 57: South America H. Pylori Test Industry Revenue Share (%), by End-user 2025 & 2033
- Figure 58: South America H. Pylori Test Industry Volume Share (%), by End-user 2025 & 2033
- Figure 59: South America H. Pylori Test Industry Revenue (million), by Country 2025 & 2033
- Figure 60: South America H. Pylori Test Industry Volume (K Unit), by Country 2025 & 2033
- Figure 61: South America H. Pylori Test Industry Revenue Share (%), by Country 2025 & 2033
- Figure 62: South America H. Pylori Test Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 2: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 3: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 4: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 5: Global H. Pylori Test Industry Revenue million Forecast, by Region 2020 & 2033
- Table 6: Global H. Pylori Test Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 7: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 8: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 9: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 10: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 11: Global H. Pylori Test Industry Revenue million Forecast, by Country 2020 & 2033
- Table 12: Global H. Pylori Test Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 13: United States H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 14: United States H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 15: Canada H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 16: Canada H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 17: Mexico H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 18: Mexico H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 20: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 21: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 22: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 23: Global H. Pylori Test Industry Revenue million Forecast, by Country 2020 & 2033
- Table 24: Global H. Pylori Test Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 25: Germany H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 26: Germany H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 27: United Kingdom H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 28: United Kingdom H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 29: France H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 30: France H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 31: Italy H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 32: Italy H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: Spain H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 34: Spain H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: Rest of Europe H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 36: Rest of Europe H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 38: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 39: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 40: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 41: Global H. Pylori Test Industry Revenue million Forecast, by Country 2020 & 2033
- Table 42: Global H. Pylori Test Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 43: China H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 44: China H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 45: Japan H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 46: Japan H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 47: India H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 48: India H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 49: Australia H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 50: Australia H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 51: South Korea H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 52: South Korea H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Rest of Asia Pacific H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 54: Rest of Asia Pacific H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 56: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 57: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 58: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 59: Global H. Pylori Test Industry Revenue million Forecast, by Country 2020 & 2033
- Table 60: Global H. Pylori Test Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 61: GCC H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 62: GCC H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: South Africa H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 64: South Africa H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 65: Rest of Middle East and Africa H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 66: Rest of Middle East and Africa H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 67: Global H. Pylori Test Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 68: Global H. Pylori Test Industry Volume K Unit Forecast, by Technology 2020 & 2033
- Table 69: Global H. Pylori Test Industry Revenue million Forecast, by End-user 2020 & 2033
- Table 70: Global H. Pylori Test Industry Volume K Unit Forecast, by End-user 2020 & 2033
- Table 71: Global H. Pylori Test Industry Revenue million Forecast, by Country 2020 & 2033
- Table 72: Global H. Pylori Test Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 73: Brazil H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 74: Brazil H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: Argentina H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 76: Argentina H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: Rest of South America H. Pylori Test Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 78: Rest of South America H. Pylori Test Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the H. Pylori Test Industry?
The projected CAGR is approximately 7.4%.
2. Which companies are prominent players in the H. Pylori Test Industry?
Key companies in the market include Meridian Bioscience, CTK Biotech Inc, Diagnostic BioSystems, Medline Industries LP, CerTest BIOTEC, Epitope Diagnostics Inc, Biohit Oyj, Bio-Rad Laboratories, CorisBioConcept SPRL, Exalenz Bioscience Ltd, Quest Diagnostics Incorporate, Thermo Fisher Scientific, TECHLAB Inc.
3. What are the main segments of the H. Pylori Test Industry?
The market segments include Technology, End-user.
4. Can you provide details about the market size?
The market size is estimated to be USD 214.4 million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Infections Diseases; Increasing Awareness about the Infections Among People.
6. What are the notable trends driving market growth?
Immunoassay Segment is Expected to Witness Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Stringent Regulatory Norms by Government.
8. Can you provide examples of recent developments in the market?
In May 2022, Biomerica, Inc. announced CE Mark for its hp+detect diagnostic test that detects Helicobacter pylori bacteria. The company will begin to market and sell its hp+detect diagnostic test in the European Union (EU) and other international countries following the registration of the product in each country in which it is sold.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "H. Pylori Test Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the H. Pylori Test Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the H. Pylori Test Industry?
To stay informed about further developments, trends, and reports in the H. Pylori Test Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence